Network


Latest external collaboration on country level. Dive into details by clicking on the dots.

Hotspot


Dive into the research topics where Michael C. MacLeod is active.

Publication


Featured researches published by Michael C. MacLeod.


Analytical Biochemistry | 1979

Simultaneous preparation of nuclear DNA, RNA, and protein from carcinogen treated-hamster embryo fibroblasts☆☆☆

Michael C. MacLeod; Betty K. Mansfield; Anne Huff; James K. Selkirk

Nuclei from hamster embryo fibroblasts treated with radioactive benzo(a)pyrene were lysed in 6 M guanidine, and nuclear macromolecules were separated by isopycnic centrifugation in Cs/sub 2/SO/sub 4/. Control experiments showed that cross-contamination of the RNA, DNA, and protein fractions was less than 2% of the total recovery of each macromolecular class. When compared to previous techniques utilizing phenol extraction, similar specific activities of bound hydrocarbon (pmol benzo(a)pyrene/mg protein or nucleic acid) were obtained. However, overall recoveries of macromolecular components were higher with the present method. In addition, recovery of undegraded histones in the density gradient preparation of nuclear protein was demonstrated by sodium dodecyl sulfate-polyacrylamide gel electrophoresis, and recovery of native DNA was demonstrated by thermal denaturation studies. Although developed specifically for work with carcinogenic hydrocarbons, the Cs/sub 2/SO/sub 4/ technique should be generally useful in cases where it is necessary to prepare all three classes of macromolecules from one batch of nuclei.


Basic life sciences | 1983

Species Heterogeneity in the Metabolic Processing of Benzo[a]pyrene

James K. Selkirk; Michael C. MacLeod; Betty K. Mansfield; Patsy A. Nikbakht; Kris C. Dearstone

The detoxification response of the organism toward chemical carcinogens is to transform these potentially toxic compounds into more polar, less lipid soluble substances that are readily excretable and therefore harmless. However, it would appear that nature has made a serious mistake in the case of chemical carcinogens. This concept can be stylized by superimposing the steps in metabolic activation upon a chemical energy activation diagram (see Figure 1). It is generally assumed that the parent molecules of an environmentally prevalent chemical carcinogen are structurally stable and relatively inactive metabolically. This assumption is not unreasonable from a teleological point of view since one would expect labile chemical substances to be rapidly degraded or oxidized, due to sunlight and weather, if released in the open environment. Synthetically prepared activated carcinogens, such as polyaromatic epoxides and nitrosamines, have been shown to possess very short half-lives under physiological conditions. Therefore, the parent compound undergoes a decrease in entropy to increase its potential energy for subsequent metabolic degradation. This change requires enzymatic transformation into a reactive intermediate antecedent to further catabolism. Current evidence shows that all known carcinogenic chemicals are electrophilic reagents that seek out nucleophilic sites inside the cells (1). The peak of the curve in Figure 1 is the zone where the electron-deficient reactive metabolite is thought to interact with nucleophilic target sites hypothesized to begin the process of malignant transformation. If no such interaction takes place, the most common reaction is hydroxylation to form a metabolically inactive polar structure that is more hydrophilic and can be readily excreted. Therefore, the major thrust of the detoxification process is to render the parent compound into a structure of greater entropy and consequently less potential to exert a toxic effect.


Progress in Nucleic Acid Research and Molecular Biology | 1983

Specificity of Interaction between Carcinogenic Polynuclear Aromatic Hydrocarbons and Nuclear Proteins: Widespread Occurrence of a Restricted Pattern of Histone Binding in Intact Cells

Michael C. MacLeod; J. C. Pelling; Thomas J. Slaga; P. A. Noghrei-Nikbakht; Betty K. Mansfield; James K. Selkirk

Publisher Summary The first steps in the induction of malignancy by chemical carcinogens involve covalent interactions with cellular macromolecules. For the widespread environmental contaminant benzo[a] pyrene (B[a]P), metabolic activation by cellular enzymes produces a number of potentially reactive metabolites. The end products of one metabolic pathway, 7,8-dihydroxy-9,10-oxy-7,8,9,10 tetrahydro-B[a]P (BPDE), are responsible for essentially all DNA adduct formation in animal cells treated with B[a]P, and a particular stereoisomer, designated (+)-anti-BPDE is thought to be the ultimate carcinogenic derivative of B[a]P. It has been shown that in hamster embryo cell nuclei treated with (+)-anti-BPDE, two of the histones of nucleosomal core, H3 and H2A are covalently modified, while the remaining core histones—H4 and H2B—are essentially unmodified. All four purified core histones, however, serve as the targets for (+)-anti-BPDE in vitro .


Chemico-Biological Interactions | 1982

Time course of metabolism of benzo[e]pyrene by hamster embryo cells and the effect of chemical modifiers☆

Michael C. MacLeod; Betty K. Mansfield; James K. Selkirk

In cultures of hamster embryo cells, benzo[a]pyrene (B[a]P) is metabolized primarily in the bay region. In contrast, little or no bay region metabolism of the noncarcinogenic isomer benzo[e]pyrene (B[e]P) could be detected during 12--96-h incubations of hamster embryo cells with 4 microM [3H]B[e]P. The upper limit to 9,10-dihydro-9,10-dihydroxy-B[e]P formation is about 0.2% of the ethyl acetate-soluble metabolites (less than 0.1% of the total metabolites). The major identified metabolites of B[e]P were 4,5-dihydro-4,5-dihydroxy B[e]P and the glucuronide conjugates of 3-OH-B[e]P and 4,5-dihydro-4,5-dihydroxy B[e]P. Simultaneous treatment of cells with either B[a]P or 7,8-benzoflavone (BF) did not induce bay region metabolism of [3H]B[e]P.


Carcinogenesis | 1982

Physical interactions of isomeric benzo[a]pyrene diol-epoxides with DNA

Michael C. MacLeod; James K. Selkirk


Carcinogenesis | 1982

Covalent binding of isomeric benzo(a)pyrene diol-epoxides to DNA

Michael C. MacLeod; Betty K. Mansfield; James K. Selkirk


Carcinogenesis | 1980

Metabolism of benzo(e)pyrene by rat liver microsomal enzymes

Michael C. MacLeod; Wayne Levin; Allan H. Conney; Roland E. Lehr; Betty K. Mansfield; Donald M. Jerina; James K. Selkirk


Proceedings of the National Academy of Sciences of the United States of America | 1980

Specificity in interaction of benzo[a]pyrene with nuclear macromolecules: implication of derivatives of two dihydrodiols in protein binding.

Michael C. MacLeod; A Kootstra; B K Mansfield; Thomas J. Slaga; James K. Selkirk


Carcinogenesis | 1982

Selective modification of nuclear proteins by polycyclic aromatic hydrocarbons and by benzo[a]pyrene diol epoxides.

Arend Kootstra; Michael C. MacLeod; Radhakrishnan Iyer; James K. Selkirk; Thomas J. Slaga


Cancer Research | 1981

Binding of Benzo( a )pyrene Derivatives to Specific Proteins in Nuclei of Intact Hamster Embryo Cells

Michael C. MacLeod; Arend Kootstra; Betty K. Mansfield; Thomas J. Slaga; James K. Selkirk

Collaboration


Dive into the Michael C. MacLeod's collaboration.

Top Co-Authors

Avatar

James K. Selkirk

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Betty K. Mansfield

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Thomas J. Slaga

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Anne Huff

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Arend Kootstra

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar
Top Co-Authors

Avatar

Donald M. Jerina

National Institutes of Health

View shared research outputs
Top Co-Authors

Avatar

J. C. Pelling

Oak Ridge National Laboratory

View shared research outputs
Top Co-Authors

Avatar

Kris C. Dearstone

Oak Ridge National Laboratory

View shared research outputs
Researchain Logo
Decentralizing Knowledge